In 2022, Halep tested positive for the drug Roxadustat in the United States. She was imposed a four-year ban, which would have ended in 2026, effectively ending her career as a professional tennis player.
Explanation of Simona Halep's ban: When is the former World No. 1 allowed to return from a drug ban?
In 2022, Halep tested positive for the drug Roxadustat in the United States. She was imposed a four-year ban, which would have ended in 2026, effectively ending her career as a professional tennis player."I'm so excited to go back on the tour," Halep remarked.
It's too soon to predict when Halep will return to competition, as a three-judge panel at the Lausanne, Switzerland-based court decided her appeal on Tuesday. It's also too soon to know the specifics of the reasoning behind the ruling, as the highest court in sports, CAS, has only released a summary of its conclusions rather than the entire document.
You should know the following regarding what transpired:
Romanian-born Halep, 32, is the best player in her sport. She rose to the top of the WTA rankings and defeated Serena Williams in the Wimbledon final in 2019 and Sloane Stephens in the French Open final in 2018 to win major titles. The foundation of Halep's game is defence and quick court coverage.
At the 2022 U.S. Open, Halep tested positive for the prohibited substance Roxadustat. She lost to Daria Snigur of Ukraine 6-2, 0-6, 6-4 in the opening round. It was Snigur's first victory at the tour level.
In 2021, roxadustat received approval for use in the European Union to treat anaemia symptoms brought on by chronic renal failure. It encourages the body to create more erythropoietin, or EPO, a naturally occurring hormone that has long been used as a performance-enhancing drug by long-distance runners and cyclists.
She received a four-year ban that was set to expire in 2026, which most likely meant her professional tennis career would be over.
Howard Jacobs, Halep's attorney, contended that Halep's failed test resulted from her exposure to a tainted supplement. Halep was found by CAS to have "some level of fault or negligence" for not utilising the supplement with "sufficient care," but "she bore no significant fault or negligence."
CAS stated that "her anti-doping rule violations were not intentional" for this reason.
Due to the test that year, Halep was temporarily suspended from participating in her sport in October 2022. Then, in May 2023, due to anomalies in her Athlete Biological Passport, she was charged by the International Tennis Integrity Agency with a second doping offence.
These passports give a baseline reading of the chemicals in an athlete's body and are thought to be useful in tracking doping because variations over time indicate possible problems.
The ITIA requested that her original sentence be increased to a total of six years. However, the verdict on Tuesday included information concerning two tests she did in September 2022, roughly two weeks apart, which made CAS "not comfortably satisfied that an anti-doping rule violation” pertaining to her passport had happened.
Most likely not. Halep "has already initiated a lawsuit against the supplement company," according to a statement made by her attorney, Jacobs, on Tuesday. Jacobs further noted that, according to the CAS panel's ruling, her suspension would have ended in July 2023, meaning she "should have been eligible" to compete in the Australian Open in January and the U.S. Open in December of last year. The French Open, which starts in May, is the next Grand Slam competition.
"Because I am and have always been a clean athlete, I have maintained my belief that the truth would eventually come out and that a just decision would be reached," Halep stated in a statement made public by Jacobs. "The outrageous charges made against me and the seemingly boundless resources stacked against me put my trust in the process to the test. Nevertheless, even though it took far longer than I had hoped, the truth eventually came to light.
إرسال تعليق